Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis.


Journal

Immunology letters
ISSN: 1879-0542
Titre abrégé: Immunol Lett
Pays: Netherlands
ID NLM: 7910006

Informations de publication

Date de publication:
03 2023
Historique:
received: 06 12 2022
revised: 13 02 2023
accepted: 23 02 2023
medline: 31 3 2023
pubmed: 28 2 2023
entrez: 27 2 2023
Statut: ppublish

Résumé

Previous evidences show that Musculin (Msc), a repressor member of basic helix-loop-helix transcription factors, is responsible in vitro for the low responsiveness of human Th17 cells to the growth factor IL-2, providing an explanation for Th17 cells rarity in inflammatory tissue. However, how and to what extent Musculin gene can regulate the immune response in vivo in an inflammatory context is still unknown. Here, exploiting two animal models of inflammatory diseases, the Experimental Autoimmune Encephalomyelitis (EAE) and the dextran sodium sulfate (DSS)-induced colitis, we evaluated the effect of Musculin gene knock-out on clinical course, performing also a deep immune phenotypical analysis on T cells compartment and an extended microbiota analysis in colitis-sick mice. We found that, at least during the early phase, Musculin gene has a very marginal role in modulating both the diseases. Indeed, the clinical course and the histological analysis showed no differences between wild type and Msc knock-out mice, whereas immune system appeared to give rise to a regulatory milieu in lymph nodes of EAE mice and in the spleen of DSS colitis-sick mice. Moreover, in the microbiota analysis, we found irrelevant differences between wild type and Musculin knock-out colitis-sick mice, with a similar bacterial strains' frequency and diversity after the DSS treatment. This work strengthened the idea of a negligible Msc gene involvement in these models.

Identifiants

pubmed: 36848960
pii: S0165-2478(23)00024-X
doi: 10.1016/j.imlet.2023.02.006
pii:
doi:

Substances chimiques

Basic Helix-Loop-Helix Transcription Factors 0
Dextran Sulfate 9042-14-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-31

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Anna Vanni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Alberto Carnasciali (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Alessio Mazzoni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Edda Russo (E)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Parham Farahvachi (P)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Leandro Di Gloria (LD)

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence 50139, Italy.

Matteo Ramazzotti (M)

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence 50139, Italy.

Giulia Lamacchia (G)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Manuela Capone (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Lorenzo Salvati (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Laura Calosi (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Daniele Bani (D)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Francesco Liotta (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Lorenzo Cosmi (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Amedeo Amedei (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Clara Ballerini (C)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Laura Maggi (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy. Electronic address: laura.maggi@unifi.it.

Francesco Annunziato (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence 50139, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH